Impact of Osmotically Active Excipients on Bioavailability and Bioequivalence of BCS Class III Drugs
Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 4
Abstract
SAPP is commonly used as a food additive and mostly found in bakery products (40). SAPP can also be employed as an excipient for effervescent formulations to provide rapid disintegration of pharmaceutical products. In a relative bioavailability study on ranitidine, it was found that co-administration of 1,132 mg (5.1 mmol) SAPP significantly reduced ranitidine absorption (54% based on AUC), which was further shown to be in parallel to a 56% decrease in small intestine transit time using scintigraphic imaging (41).
Authors and Affiliations
Mei-Ling Chen, Nakissa Sadrieh, Lawrence Yu
Keywords
Related Articles
- EP ID EP681181
- DOI 10.1208/s12248-013-9509-z
- Views 88
- Downloads 0
Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development
Model-based drug development (MBDD) has been recognized as a concept to improve the efficiency of drug development. The acceptance of MBDD from regulatory agencies, industry, and academia has been growing, yet today...
The history of bioanalytical method validation and regulation: Evolution of a guidance document on bioanalytical methods validation
Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures
Stockpiling of pre-pandemic influenza vaccines guarantees immediate vaccine availability to counteract an emerging pandemic. Generally, influenza vaccines need to be stored and handled refrigerated to prevent thermal deg...
Bioequivalence for Locally Acting Nasal Spray and Nasal Aerosol Products: Standard Development and Generic Approval
Demonstrating bioequivalence (BE) for nasal spray/aerosol products for local action has been very challenging because the relationship between the drug in systemic circulation and the drug reaching the nasal site of acti...
A Mathematical Model of the Effect of Immunogenicity on Therapeutic Protein Pharmacokinetics
A mathematical pharmacokinetic/anti-drug-antibody (PK/ADA) model was constructed for quantitatively assessing immunogenicity for therapeutic proteins. The model is inspired by traditional pharmacokinetic/pharmacodynamic...